Nota de Pesar – Dr. Bernardo Garicochea
É com profundo pesar que comunicamos o falecimento do Doutor Bernardo Garicochea, estimado oncologista clínico, hematologista e especialista em oncogenética, atuante no Grupo Oncoclínicas de São Paulo e membro do Digital Group do LACOG. Lamentamos a perda deste querido colega, cuja contribuição à pesquisa clínica brasileira foi inestimável. Nossos mais sinceros sentimentos a todos os familiares e amigos neste momento. A cerimônia de despedida será realizada amanhã, 12/10, das 16h às 19h, no Cemitério Morumby, em São Paulo.
Welcome to LACOG Educational
In the last decades, cancer clinical trials have significantly increased in Latin America, demonstrating the potential for scientific development in the region. LACOG, a non-profit academic research organization, is dedicated to develop and conduct epidemiological and clinical trials in cancer within its network of investigators in Latin America. To date the group conducted more than 70 studies, including more than 20.000 patients within 16 countries in Latin America and has more than 100 publications. The LACOG Educational project emerged as an initiative to promote cancer education for health professionals in Latin America with the aim to increase the understanding of methods in clinical trials, cancer translational research and scientific advances in cancer. We believe that improving medical education will stimulate investigators to the development of clinical research in Latin America. Our first webinar is already available on the platform. Supported by MSD, it's a video series focused on melanoma with the participation of experts around the world. Access the platform
Inscreva-se no II Simpósio LACOG Oncogeriatria
O Simpósio LACOG Oncogeriatria é um evento voltado para médicos que atuam no cuidado clínico de pacientes idosos, especificamente oncologistas e geriatras. O objetivo do evento é apresentar informações relevantes sobre o cuidado ao idoso com câncer, com abordagem prática, facilitando a tomada de decisões e permitindo a entrega adequada de tratamento a esses pacientes. O Simpósio conta com a participação de grandes nomes na área e uma grade científica de qualidade. Por meio dessa iniciativa, busca-se preencher as lacunas e desconstruir paradigmas no cuidado ao idoso com câncer. Inscreva-se gratuitamente em: https://simposiooncogeriatria.com.br/
Statement
Due to the critical situation affecting the state of Rio Grande do Sul and Porto Alegre, Headquarters of LACOG, we inform you that, to ensure the greater safety of our employees, we will be operating with reduced staff and hours. Therefore, LACOG’s operations will take place from 9:00 AM to 4:30 PM. We kindly ask for everyone's understanding and hope that everyone remains safe during this challenging period. Best regards, LACOG Team
Strategies for Equality in Cancer Care in Low- and Middle-Income Countries
Roberto Carmagnani Pestana DOI: 10.1001/jamanetworkopen.2024.4949 Full link: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2817007?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jamanetworkopen.2024.4949
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
Dr. Andrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, Adriano Gonçalves e Silva, Ana Paula Garcia Cardoso, André Deeke Sasse, André P. Fay, André Paternò Castello Dias Carneiro, Antonio Machado Alencar Junior, Augusto César de Andrade Mota, Bruno Santucci, Daniel da Motta Girardi, Daniel Herchenhorn, Daniel Vilarim Araújo, Denis Leonardo Jardim, Diogo Assed Bastos, Diogo Rodrigues Rosa, Fabio A. Schutz, Fábio Roberto Kater, Felipe da Silva Marinho, Fernando Cotait Maluf, Fernando Nunes Galvão de Oliveira, Fernando Vidigal, Igor Alexandre Protzner Morbeck, Jose Augusto Rinck Júnior, Leonardo Atem G. A. Costa, Manuel Caitano Dias Ferreira Maia, Manuela Zereu, Marcelo Roberto Pereira Freitas, Mariane Sousa Fontes Dias, Milena Shizue Tariki, Pamela Muniz, Patrícia Medeiros Milhomem Beato, Paulo Sérgio Moraes Lages, Pedro Isaacsson Velho, Ricardo Saraiva de Carvalho, Rodrigo Coutinho Mariano, Sandro Roberto de Araújo Cavallero, Thiago Martins Oliveira, Vinicius Carrera Souza, Oren Smaletz, Stênio de Cássio Zequi DOI: 10.1007/s00432-024-05663-z Full link: https://link.springer.com/article/10.1007/s00432-024-05663-z
The Lancet Comission on prostate cancer: planning for the surge in cases
Prof Nicholas D James, Ian Tannock, James N'Dow, Felix Feng, Prof Silke Gillessen, Syed Adnan Ali, Blanca Trujillo, Bissan Al-Lazikani, Gerhardt Attard, Freddie Bray, Eva Compérat, Prof Ros Eeles, Omolara FatiregunEmily Grist, Susan Halabi, Áine Haran, Daniel Herchenhorn, Michael S Hofman, Mohamed Jalloh, Stacy Loeb, Archie MacNair, Brandon Mahal, Larissa Mendes, Masood Moghul, Caroline Moore, Alicia Morgans, Michael Morris, Declan Murphy, Vedang Murthy, Paul L Nguyen, Anwar Padhani, Charles Parker, Hannah Rush, Mark Sculpher, Howard Soule, Matthew R Sydes, Derya Tilki, Nina Tunariu, Paul Villanti, Li-Ping Xie DOI: https://doi.org/10.1016/S0140-6736(24)00651-2 Full link: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00651-2/fulltext#%20
41P – Assessment of rare cancers and sarcoma policy in National Cancer Control Plans (NCCPs) from South American countries: A report from the LACOG Sarcoma Group
R. Carmagnani Pestana, D. Silva, R.A. Schmerling, R. Zon Filippi, B.B. Lopes David, V. Pires de Camargo, C. Mello, M.L. Gonzalez Donna, R. Ramella Munhoz, J.C. Haro Varas, M. Zapata, C.L. Martins, M.R. Chacon, R. Jesus-Garcia DOI: 10.1016/j.esmoop.2024.102430 Full link: https://www.esmoopen.com/article/S2059-7029(24)00198-4/fulltext